Compounded peptides and medications
A compounded medication is prepared by a licensed pharmacy for an individual prescription rather than manufactured in a factory. It's how providers prescribe compounded peptides and other molecules that have no commercial version and adjust formulations to a patient — and it comes with its own rules: compounded medications are not FDA-approved, and quality depends on the pharmacy's standards.
These articles explain how compounding works, how it's regulated, and what that means for the treatments you're prescribed.
226 articles on this topic
-
Oral TB-500: Why Capsules Lack Human Evidence
There is no human evidence that a TB-500 capsule delivers intact peptide into the bloodstream. The published TB-500 and thymosin beta-4 work used injected or topical routes, so a capsule label cannot prove absorption or an effect.
-
Semaglutide Before and After: An Honest Timeline
The first month is usually an adjustment period, month six is still part of the active curve, and a plateau often comes much later. Photos cannot show the treatment, timing, or follow-up behind a change.
-
Semax Selank Nasal Spray: What the Route Changes
A Semax Selank nasal spray puts both peptides in one intranasal liquid, but there is no universal recipe. The route, concentration, pump, and prescription all matter—and Promise's current blend is listed as an injectable vial, not a nasal spray.
-
SS-31 Protocol: What the Trials Actually Used
There is no single SS-31 cycle supported by human research. The useful evidence is narrower: a labeled plan for one rare disease and several trial schedules that cannot be copied into personal dosing advice.
-
Tesamorelin Before and After: The Study Timeline
Expect an early lab signal, not a one-month change in the mirror. The strongest trials measured deep abdominal fat at 26 and 52 weeks, all in adults with HIV-associated lipodystrophy.
-
FDA Telehealth Compounded Drugs: 5 Red Flags
FDA says telehealth sites must not present a compounded drug as a generic, a brand equivalent, or an agency-reviewed product. Here is what an honest prescription page should make clear.
-
DSIP Nasal Spray: What the Human Research Says
A DSIP nasal spray appears in one small human experiment, but no published human nasal PK or sleep trial validates the format. Promise currently lists DSIP as an injection, not a spray.
-
Generic Semaglutide Exists—Just Not in the U.S.
Canada now has authorized semaglutide generics. The U.S. has only a tentative approval, while compounded semaglutide is another category altogether.
-
Is Tesamorelin a Steroid? No—It's a GHRH Peptide
Tesamorelin is a peptide signal, not an anabolic steroid or growth hormone itself. It prompts the pituitary to release growth hormone, but sport rules still prohibit it.
-
Kisspeptin vs PT-141: They Work Differently
Kisspeptin and PT-141 both enter libido conversations, but they act on different systems and do not share the same evidence. PT-141 has larger trials and an approved branded product; kisspeptin's human data are smaller and earlier.
-
Orforglipron Is Approved: What Foundayo Changes
Orforglipron is now sold as Foundayo, a once-daily GLP-1 pill for weight management. It removes the fasting rules of oral semaglutide, but it does not replace every reason someone may choose an injection.
-
Sermorelin Before and After: A Research Timeline
The research shows hormone changes within weeks, not a predictable visible transformation. Here is what small adult studies measured at two, six, and 16 weeks.
-
Tesamorelin 10 mg: What the Vial Number Means
A tesamorelin 10 mg label describes the total peptide in the vial, not the amount in one injection. The prescribed amount, liquid volume, and days of supply come from the pharmacy label and provider's plan.
-
There Is No Best BPC-157 Brand. Ask This Instead.
No company holds an approval to make BPC-157, so the “brands” ranked online are websites, not manufacturers. What's worth comparing is the pharmacy and the prescription behind the vial.
-
CJC-1295 Ipamorelin Cost: What the Price Covers
There is no brand-name version of this blend, so there is no list price to compare against. What you are really choosing between is a prescription with a clinician attached and a vial with nobody attached.
-
Selank Dosage: What Human Studies Actually Used
Russian human studies most clearly report 2.7 mg per day intranasally for 14 days, but that fixed study protocol is not a personal dosing guide and does not convert to an injectable Semax/Selank blend.
-
Semaglutide and Kidney Disease: The Full Picture
In the largest trial on the question, serious kidney events were 24% less common on semaglutide than on placebo. The other half of the story is dehydration — and the two keep getting confused.
-
SS-31 and MOTS-c: Can You Take Them Together?
They are both mitochondrial peptides, and that is about where the similarity stops. No published trial has given people both at once — here is what each one has behind it.
-
Tirzepatide and Menopause: What the Evidence Says
Menopause does not appear to stop tirzepatide from working for weight management. The useful question is whether it fits the whole health picture, including sleep, muscle, bone and any hormone therapy already in use.
-
Tirzepatide Psoriasis Data Don’t Make It a Treatment
New 52-week data found better skin and joint outcomes when branded tirzepatide was added to Taltz in adults with psoriatic disease and obesity. That supports treating two linked conditions together—not using tirzepatide alone for psoriasis.
Page 4 of 12 · 226 articles